Fragment-Based Drug Discovery (FBDD)
Systematic screening of customized small molecule or fragment libraries. We provide Z'-factor analysis for each plate to ensure screening robustness and hit reliability.
Accelerate your drug discovery and protein characterization with our high-throughput Differential Scanning Fluorimetry (DSF) service. Also widely known as the Thermal Shift Assay (TSA), our platform provides a rapid, micro-scale solution to quantify protein thermal stability, optimize formulation buffers, and screen thousands of ligands for binding affinity. Whether you are conducting primary hit identification or rescuing aggregation-prone proteins, our biophysics team delivers precise melting temperature (Tm) data to drive your project forward.
Differential Scanning Fluorimetry (DSF) is a powerful biophysical technique used to measure the thermal stability of a protein by monitoring its unfolding as a function of increasing temperature. The assay is predicated on the thermodynamic principle that a protein’s folded state is stabilized upon the binding of a high-affinity ligand, effectively increasing the temperature required to induce denaturation.
In a standard dye-based assay, we utilize environmentally sensitive fluorescent dyes, most commonly SYPRO™ Orange. This dye is highly quenched in an aqueous environment; however, as the temperature systematically rises, the protein undergoes thermal denaturation, exposing its internal hydrophobic core. The dye binds to these newly exposed hydrophobic patches, resulting in a dramatic surge in fluorescence intensity. This emission is recorded in real-time to generate a sigmoidal melting curve.
The inflection point of this curve defines the Melting Temperature (Tm)—the temperature at which the concentrations of folded and unfolded protein are equal. By calculating the shift in Tm (ΔTm) between a control protein and a ligand-treated sample, we can confirm target engagement and qualitatively rank binding affinities.
In the modern biopharmaceutical pipeline, identifying stabilizing ligands and optimal buffer conditions is a major bottleneck. Our DSF service directly addresses critical challenges faced by structural biologists and medicinal chemists:
Rigorous Assay Development & Optimization
We do not simply run plates. Every project begins with a mandatory pre-screen to titrate protein concentration and dye-to-protein ratios. This ensures we avoid fluorescence quenching or dye-induced destabilization, providing the highest possible Signal-to-Noise (S/N) ratio for your specific target.
Advanced Data Processing for Multi-Domain Targets
Complex proteins often exhibit multi-phasic unfolding curves with multiple Tm peaks. Our analysts utilize negative first-derivative (-dF/dT) analyses and multi-peak fitting algorithms to resolve these complex transitions, ensuring that subtle interactions with specific protein domains are not missed.
Integrated False-Positive Filtering
Highly fluorescent or colored compounds in fragment libraries often cause optical interference. We actively profile chemical auto-fluorescence and, if interference is detected, we seamlessly transition the assay to our label-free Nano-DSF platform, which utilizes deep-UV intrinsic fluorescence to bypass extrinsic dye artifacts.
Seamless Orthogonal Validation
As a comprehensive biophysical CRO, we provide a closed-loop solution. Hits identified via DSF can be transitioned immediately to our Surface Plasmon Resonance (SPR) Service for kinetic profiling (kon, koff) or our Isothermal Titration Calorimetry (ITC) Analysis Service for full thermodynamic validation (ΔH, ΔS, n).
Our optimized protocols are adaptable to a wide range of biological models and R&D stages:
Systematic screening of customized small molecule or fragment libraries. We provide Z'-factor analysis for each plate to ensure screening robustness and hit reliability.
Quantifying the stabilizing effect (ΔTm) of lead compounds. This data allows for the ranking of candidates by relative binding affinity, directly guiding SAR (Structure-Activity Relationship) optimization.
Screening of the Hampton Solubility Screen or custom matrices (varying pH 3.0–10.0, salts, and additives like glycerol or EDTA) to maximize protein shelf-life and prevent aggregation.
Evaluating how point mutations, domain deletions, or fusion tags impact the global thermal stability and folding cooperativity of an engineered protein.
Determining the thermal stability of various IgG domains (CH2, CH3, and Fab) to assess the "fitness" and stability of monoclonal antibody candidates.
A common pitfall in thermal shift assays is sample incompatibility with extrinsic dyes. We offer two distinct DSF technologies to ensure we can analyze your specific target regardless of buffer or structural constraints.
| Feature | Standard Dye-Based DSF | Nano-DSF (Label-Free) |
| Detection Method | Extrinsic fluorescent dye | Intrinsic protein fluorescence |
| Signal Source | Dye binding to exposed hydrophobic core | Tryptophan/Tyrosine emission shift |
| Detergent & Lipid Compatibility | Incompatible (High background) | Highly Compatible |
| Fluorescent Compound Interference | Moderate to High risk | Very Low risk (Deep-UV excitation) |
| Sample Concentration Range | 0.1 – 1.0 mg/mL | 0.005 – 200 mg/mL |
| Ideal Use Case | Soluble protein FBDD screening. | Membrane proteins, mAbs, high-concentration formulations. |
Reliable thermal shift data relies on flawless sample preparation and baseline establishment. Our end-to-end workflow is governed by strict Quality Control (QC) gates.
The Standardized DSF/TSA Workflow: Emphasizing rigorous assay development and false-positive mitigation.
Assay Development & Pre-Screen
We titrate the target protein against varying dye concentrations to determine the optimal assay window.
QC Checkpoint 1: Baseline fluorescence stability and complete unfolding curve validation.
Auto-Fluorescence Control (QC)
Compounds are pre-evaluated for auto-fluorescence at the assay wavelengths. If chemical interference is detected, we transition the project to Nano-DSF or orthogonal methods to rule out false positives.
Automated Plate Preparation
Utilizing high-precision liquid handlers, protein, ligands (or buffer matrices), and dyes are dispensed into 96-well or 384-well plates to ensure volume consistency and reproducibility.
Thermal Ramping & Detection
Plates are subjected to a controlled temperature gradient (typically 25°C to 95°C at 1°C/min) in our advanced detection systems.
Data Fitting & Hit Identification
Raw data is processed using specialized software. Melting curves are fitted to the Boltzmann equation, and the negative first derivative is calculated to accurately pinpoint the Tm and ΔTm.
QC Checkpoint 2: Z'-factor evaluation for screening robustness and statistical significance filtering.
DSF is the ultimate "top-of-funnel" screening tool, but drug discovery requires a multi-layered approach. As a comprehensive biophysical CRO, we integrate DSF into a complete Orthogonal Screening Cascade to minimize risk and maximize confidence in your leads.
The biophysical screening cascade.
Research Objective:
A major challenge in structural biology is the inherent instability of purified recombinant proteins, which often aggregate before crystallization can occur. In a landmark methodological application of DSF, researchers sought to systematically identify buffer conditions and small-molecule ligands that could significantly enhance the thermal stability of various target proteins to facilitate structural determination.
How DSF Was Used:
Key Findings from DSF:
Why DSF Was Essential:
Reference:
Representative data analogous to Figure 2 from Niesen et al., illustrating a significant ΔTm shift upon ligand binding and the identification of optimal buffer conditions.
Your final data package is engineered to support seamless integration into your research narrative, IND applications, and high-impact journal submissions.
Standard Deliverables:
Thermal Denaturation (Melting) Curves
Demonstrating a positive ΔTm shift upon ligand binding. We provide clear plots mapping normalized fluorescence against temperature.
First Derivative Plot (-dF/dT)
Utilized to precisely determine the Tm, effectively resolving complex or multi-phasic unfolding transitions.
ΔTm Ligand Screening Distribution
Bar charts visualizing the ΔTm across the entire library, clearly highlighting "hits" that exceed the significance threshold (e.g. > 2.0°C).
Buffer Optimization Heatmap
Visually identifying the optimal pH and ionic strength for maximum protein stability. We also provide Screening Robustness (Z'-factor) plots to demonstrate reliability.
Proper sample preparation is critical for generating stable baselines. Please review our minimum requirements.
| Parameter | Standard Dye-Based DSF | Label-Free Nano-DSF | Notes |
| Protein Purity | > 85% | > 85% | Impurities can cause multi-phasic melting curves. |
| Concentration | 0.1 – 1.0 mg/mL | 0.05 – 10.0 mg/mL | Concentration is optimized during pre-screening. |
| Volume Required | > 100 μL per condition | > 50 μL per condition | Allows for technical replicates and assay development. |
| DMSO Tolerance | Up to 5% | Up to 5% | High DMSO can destabilize proteins; vehicle controls are used. |
| Detergents | Strictly Incompatible | Highly Compatible | Sypro Orange binds to micelles causing massive background noise. |
Selecting the appropriate biophysical assay depends on your project stage and throughput requirements.
| Feature | DSF / Thermal Shift Assay | Isothermal Titration Calorimetry (ITC) | Surface Plasmon Resonance (SPR) |
| Primary Output | Tm, ΔTm (Stability & Binding) | Kd, ΔH, ΔS, Stoichiometry | KD, Association (kon), Dissociation (koff) |
| Throughput | Very High (384-well format) | Low (1 sample per hour) | Medium to High |
| Sample Consumption | Ultra-Low (~1-5 μg per well) | High (~300 μL of protein) | Low (but requires immobilization) |
| Immobilization | No (In solution) | No (In solution) | Yes (Sensor chip required) |
| Best Used For | Primary hit screening, buffer optimization, qualitative ranking. | Rigorous thermodynamic validation of optimized leads. | Real-time kinetic profiling of validated hits. |
Strategy: We recommend utilizing DSF as your primary screening tool to filter large libraries. Once high-affinity hits are identified, transition to our ITC Analysis Service for full thermodynamic profiling.
1. How large of a ΔTm is considered a significant "hit"?
Generally, a positive shift (ΔTm) of > 1.5°C to 2.0°C is considered statistically significant and indicates genuine ligand binding. However, this threshold can vary depending on the target protein's inherent stability and the baseline variance of the assay. We utilize Z'-factors to establish robust statistical cut-offs for each specific project.
2. Can DSF determine the exact binding affinity (Kd)?
While the magnitude of ΔTm often correlates with binding affinity, DSF is primarily a qualitative or semi-quantitative assay. It ranks compounds based on their stabilizing effect. To determine exact Kd values, orthogonal methods like ITC or SPR are recommended.
3. Why can't I use standard dye-based DSF for my membrane protein?
Extrinsic dyes like SYPRO Orange are environmentally sensitive and fluoresce when bound to hydrophobic regions. Detergents, which are mandatory to keep membrane proteins soluble, form hydrophobic micelles. The dye will bind aggressively to these micelles, creating a massive fluorescent background that completely masks the protein's melting signal. For membrane proteins, Nano-DSF is strictly required.
4. What happens if my compound is highly fluorescent?
Highly fluorescent or colored compounds can interfere with the optical detection of dye-based DSF, leading to false positives. In such cases, Nano-DSF (which uses deep-UV intrinsic fluorescence) or orthogonal biophysical screens are deployed to rule out artifacts.
5. Does a lack of ΔTm mean the compound definitely doesn't bind?
Not necessarily. While most ligands stabilize the protein upon binding, some ligands bind equally well to both the folded and unfolded states, or induce conformational changes that do not alter global thermal stability. These are known as "silent binders." Orthogonal assays should be used if target engagement is strongly suspected despite a negative DSF result.
References
Compliance / Disclaimer
All services, data, and deliverables provided herein are for Research Use Only (RUO). Not for use in diagnostic procedures.
Online Inquiry